LUCIS: lung cancer imaging studies

Area of Science:

• Radiology
• Oncology
• Medical Imaging

Background:

• Pulmonary nodules are critical indicators of early lung cancer.
• Optimal management of solitary pulmonary nodules (SPNs) remains challenging.
• Advancements in imaging necessitate validation of diagnostic and staging methods for non-small cell lung cancer (NSCLC).

Purpose of the Study:

• To evaluate non-invasive imaging techniques for characterizing pulmonary nodules and masses.
• To assess methods for diagnosing and staging lung cancer, including NSCLC.
• To validate current diagnostic approaches and explore new methods for lung cancer detection.

Main Methods:

• Study 1: High-resolution CT (HRCT) for 213 participants with pulmonary nodules.
• Study 2: F-18-FDG PET/CT for 168 patients with pulmonary lesions.
• Study 3: Dynamic contrast-enhanced CT (DCE-CT) for 59 patients with pulmonary nodules/masses.
• Study 4: CT and F-18-FDG PET/CT for mediastinal staging in 114 NSCLC patients.

Main Results:

• HRCT effectively diagnoses and rules out cancer in SPNs using attenuation and morphology.
• F-18-FDG PET/CT showed no significant difference from CT in overall diagnostic accuracy for staging.
• DCE-CT, particularly quantitative analysis, is not currently clinically feasible for pulmonary lesions due to lack of reproducibility and discrimination.
• Standard CT is better for identifying lung cancer than ruling it out.

Conclusions:

• HRCT is a valuable tool for SPN assessment.
• F-18-FDG PET/CT and CT are comparable for mediastinal staging of NSCLC.
• DCE-CT requires further development to become clinically viable for pulmonary lesion analysis.
• There is a continued shift towards functional imaging for differentiating malignant from benign pulmonary nodules non-invasively.